20 articles
A completed clinical trial tests whether a prebiotic blend can boost Akkermansia muciniphila and support weight management in metabolic syndrome.
Small pilot study explores whether restoring gut bacteria can break the cycle of recurrent UTIs in women.
A completed trial tested whether probiotic and prebiotic supplementation could reduce premature aging-related inflammation in people living with HIV.
Small pilot study tests whether acarbose, a diabetes medication, can slow aging processes in healthy older adults through microbiome changes.
Phase 1 trial of acapatamab, a PSMA-targeting bispecific T-cell engager, enrolls 212 men with metastatic castration-resistant prostate cancer.
A completed trial examines how a key inflammation pathway connects periodontitis stages to the chronic low-grade inflammation of aging.
Clinical trial tests safety of combined prebiotic-probiotic supplement in 32 healthy participants over 5 months.
A 12-week trial tested whether a bioactive hydrolysate could reduce gut discomfort, inflammation, and blood sugar issues in healthy elderly participants.
Study explores how genetic variants influence whether plant-based or animal-based diets trigger inflammation and alter gut microbiome.
Small study tests synbiotic supplements to combat age-related immune decline in healthy elderly adults.
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
A completed trial explores whether a low-fibre diet can ease intestinal dysmotility — one of the most debilitating but overlooked symptoms of mitochondrial disease.
University study tests whether combining probiotics with prebiotics can restore healthy gut bacteria and immune function in people over 65.
A completed RCT tests whether 1-hour pathogen detection paired with antimicrobial stewardship slashes broad-spectrum antibiotic days in HAP patients.
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Small trial explores how popular greens supplement affects microbiome and blood nutrient markers in healthy adults over 7 weeks.
82-person study reveals how Mediterranean eating patterns modify intestinal microbes to improve cardiovascular and metabolic markers.
Small study explores how health education affects gut bacteria and physical decline in seniors over 12 months.
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
Clinical trial explores whether resetting gut microbiome through fecal transplants can slow Parkinson's progression and reduce symptoms.
